Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats

References

• Mazzanti R, Arena U, and Tassi R: Hepatocellular carcinoma: where are we? World J Exp Med 6, 21–36, 2016.
   PubMedGoogle Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–86, 2015.
   PubMed Web of Science ®Google Scholar
• Wong MCS, Jiang JY, Goggins WB, Liang M, Fang Y, et al.: International incidence and mortality trends of liver cancer: a global profile. Sci Rep 7, 45846, 2017.
   PubMed Web of Science ®Google Scholar
• Ghouri YA, Mian I, and Rowe JH: Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog 16, 1, 2017.
   PubMedGoogle Scholar
• Zhu RX, Seto WK, Lai CL, and Yuen MF: Epidemiology of hepatocellular carcinoma in the Asia-Pacific Region. Gut Liver 10, 332–339, 2016.
   PubMed Web of Science ®Google Scholar
• Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, et al.: Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89, 259–266, 1985.
   PubMed Web of Science ®Google Scholar
• Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, et al.: Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 16, 132–137, 1992.
   PubMed Web of Science ®Google Scholar
• Taouli B, Goh JSK, Lu Y, Qayyum A, Yeh BM, et al.: Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr 29, 425–429, 2005.
   PubMed Web of Science ®Google Scholar
• Furlan A, Marin D, Agnello F, Di Martino M, Di Marco V, et al.: Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. J Comput Assist Tomogr 36, 20–25, 2012.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, and Bruix J: Hepatocellular carcinoma. Lancet 362, 1907–1917, 2003.
   PubMed Web of Science ®Google Scholar
• Saleem S, Khan R, Afzal M, and Kazmi I: Oxyphenbutazone promotes cytotoxicity in rats and Hep3B cells via suppression of PGE2 and deactivation of Wnt/β-catenin signalling pathway. Mol Cell Biochem 444, 187–196, 2018.
   PubMed Web of Science ®Google Scholar
• Tatematsu M, Mera Y, Inoue T, Satoh K, Sato K, et al. : Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of gamma-glutamyltransferase in rat liver preneoplastic and neoplastic lesions . Carcinogenesis 9, 215–220, 1988.
   PubMed Web of Science ®Google Scholar
• Minicis SD, Kisseleva T, Francis H, Baroni GS, Benedetti A, et al. Liver carcinogenesis: Rodent models of hepatocarcinoma and cholangiocarcinoma. Dig Liver Dis 45, 450–459, 2013.
   PubMedGoogle Scholar
• Elmamoun M, and Chandran V: Role of methotrexate in the management of psoriatic arthritis. Drugs 78, 611–619, 2018.
   PubMed Web of Science ®Google Scholar
• Goujon C, Viguier M, Staumont-Sallé D, Bernier C, Guillet G, et al. Methotrexate versus cyclosporine in adults with moderate-to-severe atopic dermatitis: a phase III randomized noninferiority trial. J Allergy Clin Immunol Pract 6, 562–569, 2018.
   PubMed Web of Science ®Google Scholar
• Rajgopal A, Edmondnson A, Goldman ID, and Zhao R: SLC19A3 encodes a second thiamine transporter ThTr2. Biochim Biophys Acta 1537, 175–178, 2001.
   PubMed Web of Science ®Google Scholar
• Osiezagha K, Ali S, Freeman C, Barker NC, Jabeen S, et al. Thiamine deficiency and delirium. Innov Clin Neurosci 10, 26–32, 2013.
   PubMedGoogle Scholar
• Boros LG, Puigjaner J, Cascante M, Lee WNP, and Brandes J: Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 57, 4242–4248, 1997.
   PubMed Web of Science ®Google Scholar
• Zastre JA, Sweet RL, Hanberry BS, and Ye S: Linking vitamin B1 with cancer cell metabolism. Cancer Metab 1, 162013.
   PubMedGoogle Scholar
• Chakraborty T, Chatterjee A, Rana A, Srivastawa S, Damodaran S, et al.: Cell proliferation and hepatocarcinogenesis in rat initiated by diethyl nitrosamine and promoted by phenobarbital: potential roles of early DNA damage and liver metallothionein expression. Life Sci 81, 489–499, 2007.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Basak R, Bishayee A, Basak J, and Chatterjee M: Beta-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethyl nitrosamine. Br J Cancer 76, 855–861, 1997.
   PubMed Web of Science ®Google Scholar
• Gupta RC : Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 81, 6943–6947, 1984.
   PubMed Web of Science ®Google Scholar
• Tessitore L, Tomasi C, Greco M, Sesca E, Laconi E, et al. A sub-necrogenic dose of diethyl nitrosamine is able to initiate hepatocarcinogenesis in the rat when coupled with fasting/refeeding. Carcinogenesis 17, 289–292, 1996.
   PubMed Web of Science ®Google Scholar
• Chang W, He W, Li P-P, Song S-S, Yuan P-F, et al. Protective effects of Celastrol on diethyl nitrosamine-induced hepatocellular carcinoma in rats and its mechanisms. European J Pharmacol 784, 173–180, 2016.
   PubMed Web of Science ®Google Scholar
• Mathonnet M, Descottes B, Valleix D, Labrousse F, and Denizot Y: VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 12, 830–831, 2006.
   PubMed Web of Science ®Google Scholar
• Aebi H : Catalase in vitro. Meth Enzymol 105, 121–125, 1984.
   PubMed Web of Science ®Google Scholar
• Beuchamp FBC: Superoxide dismutase; improved assay and an assay applicable to acrylamide gel. Anal Biochem 10, 276–287, 1976.
   Google Scholar
• Nicholas MA: A spectrophotometric assay for iodide oxidation by thyroid peroxidase. Anal Biochem 4, 311–345, 1962.
   Web of Science ®Google Scholar
• Buege JA, and Aust SD: Microsomal lipid peroxidation. Methods Enzymol 52, 302–310, 1978.
   PubMedGoogle Scholar
• Balamurugan K, and Karthikeyan J: Evaluation of luteolin in the prevention of N-nitrosodiethylamine-induced hepatocellular carcinoma using animal model system. Indian J Clin Biochem 27, 157–163, 2012.
   PubMedGoogle Scholar
• Gilbert F : Chromosomes, genes, and cancer: a classification of chromosome abnormalities in cancer. J Natl Cancer Inst 71, 1107–1114, 1983.
   PubMed Web of Science ®Google Scholar
• Cerutti PA : Prooxidant states and tumor promotion . Science 227, 375–381, 1985.
   PubMed Web of Science ®Google Scholar
• Grover S, and Fischer P: Cytogenetic studies in Sprague-Dawley rats during the administration of a carcinogenic nitroso compound-diethylnitrosamine. Eur J Cancer 7, 77–82, 1971.
   PubMed Web of Science ®Google Scholar
• Hitachi PM, Yamada K, and Takayama S: Diethylnitrosamine-induced chromosomal changes in rat liver cells. J Nati Cancer Inst 53, 507–516, 1974.
   PubMedGoogle Scholar
• Martinek R: Practical clinical enzymology. Am J Med Technol 31, 162, 1969.
   Google Scholar
• Drotman RB, and Lawhorn GT : Serum enzymes as indicators of chemically induced liver damage. Drug Chem Toxicol 1, 163–171, 1978.
   PubMed Web of Science ®Google Scholar
• Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, and Min AD: Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 95, 1535–1538, 2000.
   PubMed Web of Science ®Google Scholar
• McIntyre N, and Rosalki S: Biochemical investigation in the management of liver disease. In: Hepatobiliary Diseases, Prieto J, Rodes J, Shafritz DA (eds.). Berlin: Springer, 1992, pp. 39–71.
   Google Scholar
• Clawson GA : Mechanisms of carbon tetrachloride hepatotoxicity. Pathol Immunopathol Res 8, 104–112, 1989.
   PubMedGoogle Scholar
• Chan SL, Mo FKF, Johnson PJ, Hui EP, Ma BBY, et al. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. J Clin Oncol 27, 446–452, 2009.
   PubMed Web of Science ®Google Scholar
• Ploa GL, and Hewitt WR: Detection and evaluation of chemically induced liver injury. In: Principle and Methods of Toxicology, Wallace HA (ed). New York: Raven Press, 1989, p 399.
   Google Scholar
• Kuzuya T, Asahina Y, Tsuchiya K, Tanaka K, Suzuki Y, et al. Early decrease in alpha-fetoprotein, but not des-gamma-carboxy prothrombin, predicts sorafenib efficacy in patients with advanced hepatocellular carcinoma. Oncology 81, 251–258, 2011.
   PubMed Web of Science ®Google Scholar
• Shao YY, Lin ZZ, Hsu C, Shen YC, Hsu CH, and Cheng AL: Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma. Cancer 116, 4590–4596, 2010.
   PubMed Web of Science ®Google Scholar
• Keam B, Oh DY, Lee SH, Kim DW, Im SA, et al. A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker. Mol Med Rep 1, 415–422, 2008.
   PubMed Web of Science ®Google Scholar
• Trebukhina RV, Ostrovsky YM, Shapot VS, Mikhaltsevich GN, and Tumanov VN: Turnover of [14C] thiamin and activities of thiamin pyrophosphatedependent enzymes in tissues of mice with Ehrlich ascites carcinoma. Nutr Cancer 6, 260–273, 1985.
   Google Scholar
• Trebukhina RV, Ostrovsky Yu M, Shapot VS, Petushok VG, Velichko MG, et al. Thiamine metabolism in the liver of mice with Ehrlich ascites carcinoma. Neoplasma 29, 257–268, 1982.
   PubMed Web of Science ®Google Scholar
• Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8, 128–135, 2002.
   PubMed Web of Science ®Google Scholar
• Yang ZF, and Poon R: Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken) 291, 721–734, 2008.
   PubMedGoogle Scholar
• Tersitore Bonelli LG, and Baccino FM: Early development of protein metabolic perturbation in the liver and skeletal muscle of tumours leasing rats. Biochem J 241, 153–159, 1987.
   PubMed Web of Science ®Google Scholar
• Waterhouse C, Pretre NJ, and Keilson J: Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 39, 1968–1972, 1979.
   PubMed Web of Science ®Google Scholar
• Lunt SY, and Vander H: Aerobid glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27, 441–464, 2011.
   PubMed Web of Science ®Google Scholar
• Sherman CD, Morton JJ, and Mider GB: Potential source of tumour nitrogen. Cancer Res 10, 374–378, 1950.
   PubMed Web of Science ®Google Scholar
• Tarnawski AS, and Michael KJ: Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. J Mol Med 81, 627–636, 2003.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, and Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186, 407–421, 1990.
   PubMed Web of Science ®Google Scholar
• Hietanen E, Ahotupa M, and Bartsch H: Lipid peroxidation and chemically induced cancer in rats fed lipid rich diet. In: Carcinogeensis and Tumor Progression. Lapis K, Kcharst S (eds.). Budapest: Akademiaikiado. 9–16, 1987.
   Google Scholar
• Klaunig JE, and Kamendulis LM: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44, 239–267, 2004.
   PubMed Web of Science ®Google Scholar
• Heinrich P, Georg L, and Petro E: Biochemie Und Pathobiochemie. (Springer-Lehrbuch) (German Edition). Berlin: Springer, 399, 2006.
   Google Scholar